Search
Filter by Topic
- People (146) Apply People filter
- Reproduction (57) Apply Reproduction filter
- Publications (36) Apply Publications filter
- Legal (27) Apply Legal filter
- Technologies (27) Apply Technologies filter
- Experiments (25) Apply Experiments filter
- Processes (24) Apply Processes filter
- Theories (20) Apply Theories filter
- Disorders (14) Apply Disorders filter
- Outreach (9) Apply Outreach filter
- Ethics (8) Apply Ethics filter
- Religion (8) Apply Religion filter
- Organizations (7) Apply Organizations filter
- Reproductive Health Arizona (4) Apply Reproductive Health Arizona filter
- Organisms (3) Apply Organisms filter
- Places (3) Apply Places filter
- DNA (1) Apply DNA filter
- RHAZ (1) Apply RHAZ filter
"Hybrids and Chimeras: A report on the findings of the consultation" by the Human Fertilisation and Embryology Authority in October, 2007
In 2007, the Human Fertilisation and Embryology Authority in London, UK, published Hybrids and Chimeras: A Report on the Findings of the Consultation, which summarized a public debate about research on, and suggested policy for, human animal chimeras. The HFEA formulated the report after conducting a series of surveys and debates from earlier in 2007. The HFEA issued a statement in September 2007, followed by an official report published on 1 October 2007. Their report on human-animal chimeras set a worldwide precedent for discussions of the ethical use of those embryos in labs.
Format: Articles
Subject: Publications, Legal, Outreach
Breast Augmentation Techniques
Breast augmentation involves the use of implants or fat tissue to increase patient breast size. As of 2019, breast augmentation is the most popular surgical cosmetic procedure in the United States, with annual patient numbers increasing by 41 percent since the year 2000. Since the first documented breast augmentation by surgeon Vincenz Czerny in 1895, and later the invention of the silicone breast implant in 1963, surgeons have developed the procedure into its own specialized field of surgery, creating various operating techniques for different results.
Format: Articles
Subject: Technologies, Processes, Reproduction, Ethics
Zidovudine or azidothymidine
In 1964, Jerome Horwitz synthesized the drug zidovudine, commonly abbreviated ZDV, otherwise known as azidothymidine, or AZT, at Wayne State University School of Medicine in Detroit, Michigan. Horwitz and his colleagues originally developed zidovudine to treat cancers caused by retroviruses. In 1983, Nobel Prize in Physiology or Medicine recipients Françoise Barré-Sinoussi and Luc Montagnier discovered a new retrovirus, the human immunodeficiency virus, or HIV, at the Pasteur Institute in Paris, France.
Format: Articles
Subject: Processes
Vincenz Czerny (1842–1916)
Vincenz Czerny was a surgeon in the nineteenth century who specialized in cancer and women’s surgical care. Czerny performed one of the first breast augmentations using a reconstruction method to correct asymmetry and disfigurement of a woman’s breasts. Additionally, Czerny improved the safety and efficacy of existing operations, such as the vaginal hysterectomy, which involves the surgical removal of some or all of a woman’s reproductive structures. He contributed to other surgeries involving the esophagus, kidneys, and intestines.
Format: Articles
Subject: People, Reproduction
HeLa Cell Line
The HeLa cell line was the first immortal human cell line that George Otto Gey, Margaret Gey, and Mary Kucibek first isolated from Henrietta Lacks and developed at The Johns Hopkins Hospital in Baltimore, Maryland, in 1951. An immortal human cell line is a cluster of cells that continuously multiply on their own outside of the human from which they originated. Scientists use immortal human cell lines in their research to investigate how cells function in humans.
Format: Articles
Subject: Technologies, Experiments, People, Ethics